Bogart Wealth LLC Acquires 10,573 Shares of CVS Health Co. (NYSE:CVS)

Bogart Wealth LLC increased its position in CVS Health Co. (NYSE:CVS) by 12.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 97,613 shares of the pharmacy operator’s stock after purchasing an additional 10,573 shares during the period. Bogart Wealth LLC’s holdings in CVS Health were worth $7,707,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Atticus Wealth Management LLC lifted its holdings in shares of CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. Cornerstone Planning Group LLC lifted its stake in CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 243 shares in the last quarter. ZRC Wealth Management LLC lifted its stake in CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 400 shares in the last quarter. Coston McIsaac & Partners lifted its stake in CVS Health by 42.6% during the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after acquiring an additional 161 shares in the last quarter. Finally, Tennessee Valley Asset Management Partners bought a new position in CVS Health during the 4th quarter valued at $50,000. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Up 0.4 %

CVS stock traded up $0.23 on Thursday, reaching $55.14. The company’s stock had a trading volume of 1,671,366 shares, compared to its average volume of 11,769,315. The business has a fifty day simple moving average of $71.95 and a two-hundred day simple moving average of $73.09. CVS Health Co. has a 12-month low of $53.70 and a 12-month high of $83.25. The firm has a market cap of $69.22 billion, a PE ratio of 9.64, a PEG ratio of 0.88 and a beta of 0.56. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm had revenue of $88.44 billion for the quarter, compared to analysts’ expectations of $89.33 billion. During the same period in the prior year, the business posted $2.20 EPS. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, research analysts forecast that CVS Health Co. will post 7.03 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.82%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s payout ratio is currently 46.75%.

Insider Buying and Selling at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now directly owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Edward J. Ludwig purchased 1,000 shares of CVS Health stock in a transaction on Thursday, May 2nd. The stock was bought at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The disclosure for this purchase can be found here. 0.24% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CVS. Truist Financial restated a “buy” rating and set a $66.00 price objective (down from $90.00) on shares of CVS Health in a research note on Thursday, May 2nd. Argus decreased their target price on CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday. TD Cowen lowered CVS Health from a “buy” rating to a “hold” rating and decreased their target price for the company from $99.00 to $59.00 in a research report on Tuesday. StockNews.com lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Finally, Leerink Partnrs lowered CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 1st. Nine analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $76.75.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.